Clinical Trials That Have Informed the Modern Management of Breast Cancer

Area of Science:

• Oncology
• Surgical Oncology
• Clinical Trials

Background:

• Randomized controlled trials (RCTs) are pivotal in advancing breast cancer management.
• Historical evolution of treatment strategies has been significantly influenced by landmark RCTs.
• Current breast cancer care aims to balance disease control, survival, quality of life, and complication minimization.

Purpose of the Study:

• To review landmark randomized controlled trials that have shaped breast cancer management.
• To highlight key trials influencing surgical extent, axillary staging, and systemic therapy selection.
• To discuss the role of genomic assays in guiding treatment decisions.

Main Methods:

• Literature review of seminal randomized controlled trials in breast cancer.
• Analysis of trials focusing on surgical techniques (e.g., mastectomy vs. breast conservation).
• Examination of studies on axillary lymph node evaluation and management.
• Review of neoadjuvant and adjuvant therapy trials, including chemotherapy and endocrine therapy selection based on genomic profiling.

Main Results:

• Trials have established breast-conserving surgery as a viable option for many patients.
• Evidence from RCTs has refined axillary staging and management protocols.
• Neoadjuvant and adjuvant therapies have demonstrated significant improvements in survival outcomes.
• Genomic assays have enabled personalized selection between chemotherapy and endocrine therapy.

Conclusions:

• Landmark RCTs provide the foundation for evidence-based breast cancer management.
• Ongoing research continues to refine surgical and systemic treatment approaches.
• Personalized medicine, guided by genomic assays, is increasingly important in optimizing breast cancer care.